Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Chordoma × palbociclib × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Estrogen Receptor-positive Breast Cancer 2 Thyroid Neoplasms 1 Thymus Neoplasms 1 Thrombosis 1 Thromboembolism 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Lung Neoplasms 1 Inflammation 1 Immune System Diseases 1 HER2+ Breast Cancer 1 Gastrointestinal Neoplasms 1 Endometrial Neoplasms 1 ER Positive, HER2 Negative Breast Cancer 1 Colonic Neoplasms 1 Chordoma 1 Cardiovascular Diseases 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors 1 Breast Diseases 1 Brain Neoplasms 1

Interventions

Protons 2 palbociclib 1 camrelizumab 1 apatinib 1 Panobinostat 1 Mastectomy, Segmental 1 Imatinib Mesylate 1 Gelclair 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03242382 2024-01-23

PalboSarc

Grupo Espanol de Investigacion en Sarcomas

Phase 2 Unknown

Chordoma, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡